看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。+ Z4 w' I5 v3 d) C$ N: p
4 @' Z" x. K' n- z/ c, Y
9 M4 ]% m5 h& z# {2 J; ZCurrently available feasibility data for possible combination strategies.
) q$ h6 L3 w' q————————————————————————————————& v- U- `: m- t9 Y
Combination Feasibility according to preliminary data
( q. t4 u# y6 y——————————————————————————————————( D3 l4 g6 Z; U& a- a
Bevacizumab + sorafenib Yes, reduced dose + l7 Y$ ?4 D/ L! R I
Bevacizumab + sunitinib† No ; r% O! q8 \8 D0 A( k
Bevacizumab + temsirolimus Yes - X0 n* |4 f- t9 `0 z; ^. A* Z
Bevacizumab + everolimus Yes
9 t: @" g9 \- C' `4 V, X% y# ISorafenib + sunitinib ?
* F5 c3 h( C' u7 m2 l5 PSorafenib + temsirolimus Yes, reduced dose : `) L9 [' g! S! |
Sorafenib + everolimus Yes, reduced dose
& f, L5 @# m. I. ISunitinib + temsirolimus† No
5 c- ^; s0 O- a7 _# v3 U- TSunitinib + everolimus ?
( h, i6 b" b" Y7 ]6 oTemsirolimus + everolimus ?
& n4 d8 x3 h1 U- @& \# f————————————————————
; h# d( O8 b8 _ ~# W†Led to US FDA warning.& r* J3 ~4 s0 N6 t! {7 ]: |
?: As yet unattempted combination.- g8 ?/ l3 v1 _* ^. B7 N: p+ d4 R
|